Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Upcoming Webinar – Developing and Optimizing Cell-based Microplate Assays

28 Nov 2012 - 28 Nov 2012 - Webinar - Online



Bookmark and Share


Looking to perform a microplate cell-based assay for the first time or would like to develop a higher throughput for your current cell-based assay? On November 28th at noon EST a webinar will be hosted by Drug Discovery and Development and BMG LABTECH, the Microplate Reader Company, to discuss developing and optimizing cell-based assays in a microplate format.
 
Many researchers look to translate their biochemical microplate assay to a cell-based format because biochemical assays can be limiting and misleading in the information that they provide. This growing trend has caused a surge in the development of many new cell-based microplate assays, as well as new developments in the instrumentation used to optimize these cell-based microplate assays.

In this webinar, three speakers will present some of the different aspects involved in developing and optimizing cell-based assays in a microplate format. Please join us to learn more about:

•    Optimizing Measurements for Microplate Cell-based Assays; Catherine Wark, BMG LABTECH, UK
•    Miniaturization and Automation of HTRF® Cell-based Assays with the Echo® Liquid Handler; Bonnie Edwards, Labcyte, Inc., USA
•    Identification and characterization of allosteric modulators of GPCRs using an HTRF® cellular assay; Jeff Jerman, PhD, MRC Technology, UK


Join us on: Wednesday, November 28th at 12:00 EST. Participation in this webinar is free and we look forward to you joining us. For more information visit: http://www.bmglabtech.com/webinar/cell-based-assays.cfm.



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!